Tau protein
The tau proteins (abbreviated from tubulin associated unit
Pathologies and
Function
Microtubule stabilization
Tau proteins are found more often in neurons than in non-neuronal cells in humans. One of tau's main functions is to modulate the stability of axonal
Although tau is present in
In addition to its microtubule-stabilizing function, Tau has also been found to recruit signaling proteins and to regulate microtubule-mediated axonal transport.[18]
mRNA translation
Tau is a negative regulator of mRNA
Behavior
The primary non-cellular functions of tau is to negatively regulate long-term memory[13] and to facilitate habituation (a form of non-associative learning),[13] two higher and more integrated physiological functions. Since regulation of tau is critical for memory, this could explain the linkage between tauopathies and cognitive impairment.
In mice, while the reported tau knockout strains present without overt phenotype when young,[14][23][24] when aged, they show some muscle weakness, hyperactivity, and impaired fear conditioning.[25] However, neither spatial learning in mice,[25][26][27] nor short-term memory (learning) in Drosophila[13] seems to be affected by the absence of tau.
In addition, tau knockout mice have abnormal sleep-wake cycle, with increased wakefulness periods and decreased non-rapid eye movements (NREM) sleep time.[28]
Other functions
Other typical functions of tau include
Genetics
In humans, the MAPT gene for encoding tau protein is located on
The MAPT gene has two haplogroups, H1 and H2, in which the gene appears in inverted orientations. Haplogroup H2 is common only in Europe and in people with European ancestry. Haplogroup H1 appears to be associated with increased probability of certain dementias, such as Alzheimer's disease. The presence of both haplogroups in Europe means that recombination between inverted haplotypes can result in the lack of one of the functioning copies of the gene, resulting in congenital defects.[32][33][34][35]
Structure
Six tau isoforms exist in human brain tissue, and they are distinguished by their number of binding
Phosphorylation of tau is regulated by a host of kinases, including PKN, a serine/threonine kinase. When PKN is activated, it phosphorylates tau, resulting in disruption of microtubule organization.[37] Phosphorylation of tau is also developmentally regulated. For example, fetal tau is more highly phosphorylated in the embryonic CNS than adult tau.[38] The degree of phosphorylation in all six isoforms decreases with age due to the activation of phosphatases.[39] Like kinases, phosphatases too play a role in regulating the phosphorylation of tau. For example, PP2A and PP2B are both present in human brain tissue and have the ability to dephosphorylate Ser396.[40] The binding of these phosphatases to tau affects tau's association with microtubules.
Phosphorylation of tau has also been suggested to be regulated by O-GlcNAc modification at various Ser and Thr residues.[41]
Mechanism
The accumulation of hyperphosphorylated tau in neurons is associated with neurofibrillary degeneration.[42] The actual mechanism of how tau propagates from one cell to another is not well identified. Also, other mechanisms, including tau release and toxicity, are unclear. As tau aggregates, it replaces tubulin, which in turn enhances fibrilization of tau.[43] Several propagation methods have been proposed that occur by synaptic contact such as synaptic cell adhesion proteins, neuronal activity and other synaptic and non-synaptic mechanisms.[44] The mechanism of tau aggregation is still not completely elucidated, but several factors favor this process, including tau phosphorylation and zinc ions.[45][46]
Release
Tau involves in uptake and release process, which is known as seeding. Uptake of tau protein mechanism requires the presence of
Toxicity
Tau causes toxic effects through its accumulation inside cells. Many enzymes are involved in toxicity mechanism such as
Clinical significance
Gender-specific tau gene expression across different regions of the human brain has recently been implicated in gender differences in the manifestations and risk for tauopathies.[55] Some aspects of how the disease functions also suggest that it has some similarities to prion proteins.[56]
Tau hypothesis of Alzheimer's disease
The
Tau mutations have many consequences, including microtubule dysfunction and alteration of the expression level of tau isoforms.
Hyperphosphorylated forms of tau protein are the main component of PHFs of NFTs in the brain of AD patients. It has been well demonstrated that regions of tau six-residue segments, namely PHF6 (VQIVYK) and PHF6* (VQIINK), can form tau PHF aggregation in AD. Apart from the PHF6, some other residue sites like Ser285, Ser289, Ser293, Ser305 and Tyr310, located near the C-terminal of the PHF6 sequences, play key roles in the phosphorylation of tau.
A68 is a name sometimes given (mostly in older publications) to the
In 2020, researchers from two groups published studies indicating that an immunoassay blood test for the p-tau-217 form of the protein could diagnose Alzheimer's up to decades before dementia symptoms were evident.[67][68][69]
Traumatic brain injury
Repetitive mild
Prion-like propagation hypothesis
The term "prion-like" is often used to describe several aspects of tau pathology in various
Interactions
Tau protein has been shown to
- Alpha-synuclein,[78][79]
- FYN,[80]
- Proto-oncogene tyrosine-protein kinase Src
- S100B,[81][82] and
- YWHAZ.[83]
See also
- Tauopathy, a class of diseases associated with accumulated tau proteins
- Dementia pugilistica
- Alzheimer's disease
- Primary age-related tauopathy
- Aging-related tau astrogliopathy
- Corticobasal degeneration
- Progressive supranuclear palsy
- Proteopathy
- Pick's disease
- Frontotemporal dementia and parkinsonism linked to chromosome 17
- Prion
References
- ^ a b c ENSG00000276155, ENSG00000277956 GRCh38: Ensembl release 89: ENSG00000186868, ENSG00000276155, ENSG00000277956 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000018411 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ PMID 1057175.
- PMID 3131773.
- S2CID 19627629.
- PMID 35765081.
- PMID 1903170.
- PMID 20678581.
- ^ PMID 599557.
- PMID 146092.
- ^ PMID 31488613.
- ^ S2CID 4322543.
- ^ S2CID 32708424.
- PMID 22720190.
- S2CID 18776289.
- PMID 15642108.
- PMID 31268600.
- ^ PMID 26791227.
- PMID 34147135.
- PMID 30759285.
- PMID 11228161.
- S2CID 25235996.
- ^ S2CID 31204860.
- S2CID 32771613.
- PMID 20434528.
- PMID 20555133.
- PMID 29187252.
- PMID 3103857.
- PMID 15615637.
- S2CID 38047848.
- PMID 19165922.
- PMID 18648385.
- PMID 16042549.
- PMID 9169588.
- PMID 11104762.
- S2CID 94265621.
- PMID 7983034.
- S2CID 40592137.
- PMID 15249677.
- PMID 8990203.
- PMID 19282288.
- PMID 25981034.
- PMID 30580037.
- PMID 30823892.
- PMID 28772101.
- PMID 29238289.
- PMID 26436904.
- S2CID 18896805.
- PMID 18930955.
- PMID 15823754.
- PMID 11381127.
- ^ a b "Alzheimer's Brain Tangles." Alzheimer's Association, www.alz.org/braintour/tangles.asp.
- PMID 27878758.
- PMID 22561167.
- PMID 19742193.
- S2CID 6799990.
- S2CID 38730940.
- S2CID 37380445.
- PMID 30893872.
- PMID 25339173.
- PMID 8393578.
- S2CID 23900723.
- PMID 35008886.
- ^ "A68", The Free Dictionary, retrieved 2020-01-27
- ISSN 0362-4331. Retrieved 2020-07-29.
- PMID 32725127.
- PMID 32722745.
- ^ "Brain Trauma". NOVA. PBS Online by WGBH.
- S2CID 196391183.
- PMID 22593173.
- PMID 23208308.
- PMID 22116192.
- Julia Evangelou Strait (December 13, 2011). "High levels of tau protein linked to poor recovery after brain injury". Washington University in St. Louis.
- S2CID 211475911, retrieved 2021-03-18
- PMID 24493463.
- PMID 31257249.
- PMID 10464279.
- S2CID 9086733.
- PMID 11826099.
- PMID 11264299.
- PMID 2833519.
- PMID 10840038.
Further reading
- Goedert M, Crowther RA, Garner CC (May 1991). "Molecular characterization of microtubule-associated proteins tau and MAP2". Trends in Neurosciences. 14 (5): 193–9. S2CID 44928661.
- Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, et al. (1995). "Hyperphosphorylation of tau in PHF". Neurobiology of Aging. 16 (3): 365–71, discussion 371–80. S2CID 22471158.
- Heutink P (April 2000). "Untangling tau-related dementia". Human Molecular Genetics. 9 (6): 979–86. PMID 10767321.
- Goedert M, Spillantini MG (July 2000). "Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1502 (1): 110–21. PMID 10899436.
- Morishima-Kawashima M, Ihara Y (November 2001). "[Recent advances in Alzheimer's disease]". Seikagaku. The Journal of Japanese Biochemical Society. 73 (11): 1297–307. PMID 11831025.
- Blennow K, Vanmechelen E, Hampel H (2002). "CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease". Molecular Neurobiology. 24 (1–3): 87–97. S2CID 24891421.
- Ingram EM, Spillantini MG (December 2002). "Tau gene mutations: dissecting the pathogenesis of FTDP-17". Trends in Molecular Medicine. 8 (12): 555–62. PMID 12470988.
- Pickering-Brown S (2004). "The tau gene locus and frontotemporal dementia". Dementia and Geriatric Cognitive Disorders. 17 (4): 258–60. S2CID 27693523.
- van Swieten JC, Rosso SM, van Herpen E, Kamphorst W, Ravid R, Heutink P (2004). "Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17". Dementia and Geriatric Cognitive Disorders. 17 (4): 261–4. S2CID 36197015.
- Kowalska A, Jamrozik Z, Kwieciński H (2004). "Progressive supranuclear palsy--parkinsonian disorder with tau pathology". Folia Neuropathologica. 42 (2): 119–23. PMID 15266787.
- Rademakers R, Cruts M, van Broeckhoven C (October 2004). "The role of tau (MAPT) in frontotemporal dementia and related tauopathies". Human Mutation. 24 (4): 277–95. S2CID 28578030.
- Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, et al. (April 2005). "Tau phosphorylation in Alzheimer's disease: pathogen or protector?". Trends in Molecular Medicine. 11 (4): 164–9. PMID 15823754.
- Hardy J, Pittman A, Myers A, Gwinn-Hardy K, Fung HC, de Silva R, et al. (August 2005). "Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens". Biochemical Society Transactions. 33 (Pt 4): 582–5. PMID 16042549.
- Deutsch SI, Rosse RB, Lakshman RM (December 2006). "Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30 (8): 1369–80. S2CID 6848053.
- Williams DR (October 2006). "Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau". Internal Medicine Journal. 36 (10): 652–60. S2CID 19357113.
- Pittman AM, Fung HC, de Silva R (October 2006). "Untangling the tau gene association with neurodegenerative disorders". Human Molecular Genetics. 15. 15 Spec No 2 (Review Issue 2): R188-95. PMID 16987883.
- Roder HM, Hutton ML (April 2007). "Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease". Expert Opinion on Therapeutic Targets. 11 (4): 435–42. S2CID 36430988.
- van Swieten J, Spillantini MG (January 2007). "Hereditary frontotemporal dementia caused by Tau gene mutations". Brain Pathology. 17 (1): 63–73. S2CID 40879765.
- Caffrey TM, Wade-Martins R (July 2007). "Functional MAPT haplotypes: bridging the gap between genotype and neuropathology". Neurobiology of Disease. 27 (1): 1–10. PMID 17555970.
- Delacourte A (2005). "Tauopathies: recent insights into old diseases". Folia Neuropathologica. 43 (4): 244–57. PMID 16416389.
- Hirokawa N, Shiomura Y, Okabe S (October 1988). "Tau proteins: the molecular structure and mode of binding on microtubules". The Journal of Cell Biology. 107 (4): 1449–59. PMID 3139677.
External links
- tau+Proteins at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- GeneReviews/NCBI/NIH/UW entry on MAPT-Related Disorders
- MR scans of variant CJD CSF tau-positive man
- Overview of all the structural information available in the PDB for UniProt: P10636 (Microtubule-associated protein tau) at the PDBe-KB.